Company profile: Psyadon
1.1 - Company Overview
Company description
- Provider of discovery and development of new treatments for serious psychiatric and neurological diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Psyadon
Wallaby Medical
HQ: United States
Website
- Description: Provider of the Avenir coil system and medical devices for stroke treatment, operating as a manufacturing company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wallaby Medical company profile →
Vivoryon Therapeutics
HQ: Germany
Website
- Description: Provider of biopharmaceutical R&D and clinical development focused on small molecule medicines for Alzheimer’s disease and cancer, including varoglutamstat (QPCT inhibitor, Phase 2) and a portfolio of QPCT/L inhibitors, supported by a comprehensive clinical program. Holds a strategic licensing partnership with Simcere for varoglutamstat and a preclinical monoclonal N3pE‑antibody in Greater China.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivoryon Therapeutics company profile →
Achieve Life Sciences
HQ: United States
Website
- Description: Provider of specialty pharmaceutical products, manufacturing and developing cytisinicline, a plant-based alkaloid for nicotine addiction, including smoking and e-cigarette cessation, that interacts with nicotine receptors to reduce withdrawal symptoms and the reward associated with nicotine products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Achieve Life Sciences company profile →
Vitro Biopharma
HQ: United States
Website
- Description: Provider of stem cell therapy, cell lines, and cell culture media, including AlloRx Stem Cell therapy from Wharton’s jelly–derived MSCs for autoimmune and inflammatory disorders; MSC-Gro specialty media for MSC growth and expansion; research-grade cancer-associated and native fibroblasts; human umbilical cord and placenta-derived MSC lines; and MSC-Gro formulations (low serum, serum-free, CAF-specific).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitro Biopharma company profile →
Marinus Pharmaceuticals
HQ: United States
Website
- Description: Provider of drugs and clinical research for seizure disorders. Offerings include ganaxolone, a GABAA receptor modulator for status epilepticus and rare epilepsies. The company reformulates, develops, and commercializes therapies and conducts clinical trials, and also targets neurological, psychiatric, and pain disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marinus Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Psyadon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Psyadon
2.2 - Growth funds investing in similar companies to Psyadon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Psyadon
4.2 - Public trading comparable groups for Psyadon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →